Article
DiffInvex identifies evolutionary shifts in driver gene repertoires during tumorigenesis and chemotherapy.
Nature communications - 13 May 2025
Khalil Ahmed, Supek Fran
Abstract excerpt
Somatic cells can transform into tumors due to mutations, and the tumors further evolve towards increased aggressiveness and therapy resistance. We develop DiffInvex, a framework for identifying changes in selection acting on individual genes in somatic genomes, drawing on an empirical mutation rate baseline derived from non-coding DNA that accounts for shifts in neutral mutagenesis during cancer evolution. We...
Read the complete abstract on PubMedTopics
- Humans
- Neoplasms
- Drug Resistance, Neoplasm
- Carcinogenesis
- Evolution, Molecular
- Antineoplastic Agents
- Mutation
